Why a single chart is not evidence
Online calculators often assume the stated vial amount is accurate and the material behaves like another formulation. Those assumptions are not established by a generic product page.
A concentration calculation can describe arithmetic, but it cannot validate identity, sterility, excipients, compatibility, or stability. This page therefore does not convert a research-vendor vial into administration instructions.
What a defensible record includes
- A lot-specific certificate of analysis with identity and assay information.
- A product-specific specification that identifies the formulation and fill amount.
- Stability and handling evidence for that exact formulation.
- A documented laboratory protocol appropriate to the approved research setting.
What this evidence review covers
Explain formulation-specific GHK-Cu handling limits without a universal chart.
- Identify the product form first
- Required manufacturer evidence
- Mass/concentration distinction
- Copper-peptide formulation sensitivity
- No calculator or injection instructions
Source-backed findings
Each claim below is tied to the evidence class that can support it. Commercial listing data and clinical evidence remain separate.
source limitation
Preclinical GHK-Cu studies used specific experimental preparations and do not validate retail-vial mixing.
regulatory
Injectable product characterization and impurity risks are material FDA concerns.
| Evidence class | What the source supports |
|---|---|
| source limitation | Preclinical GHK-Cu studies used specific experimental preparations and do not validate retail-vial mixing. |
| regulatory | Injectable product characterization and impurity risks are material FDA concerns. |
Source-by-source evidence notes
These notes state what each inspected source can support and the boundary that should not be crossed when interpreting it.
GHK-Cu stimulation of collagen synthesis in fibroblast culture
Evidence class: primary in vitro. What it supports: Collagen synthesis under defined cell-culture conditions.
What it does not establish: Clinical skin, hair, wound, or injectable outcomes.
GHK-Cu connective-tissue accumulation in rat experimental wounds
Evidence class: primary animal. What it supports: Extracellular-matrix findings in a rat wound model.
What it does not establish: Human treatment outcomes or injectable dosing.
FDA bulk substances that may present significant safety risks
Evidence class: primary regulatory. What it supports: FDA's BPC-157, injectable GHK-Cu, and TB-500 fragment safety/characterization statements; no identified human TB-500 fragment exposure data.
What it does not establish: A diagnosis, individual risk estimate, or claim that topical GHK-Cu and injectable GHK-Cu share one risk profile.
Questions this page answers
How much diluent should be added?
Do not provide a generic ratio without validated instructions for the exact product.
Does blue color prove identity or concentration?
No. Appearance alone is not an identity, purity, concentration, or sterility test.
What remains unresolved
- No product-specific validated instructions.
- No independent stability or sterility data.